The STIM1 inhibitor ML9 disrupts basal autophagy in cardiomyocytes by decreasing lysosome content.

Toxicol In Vitro

Advanced Center for Chronic Disease (ACCDiS) & Center of Exercise, Metabolism and Cancer (CEMC), Faculty of Chemical & Pharmaceutical Sciences & Faculty of Medicine, University of Chile, Santiago, Chile; Department of Internal Medicine (Cardiology Division), University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address:

Published: April 2018

Stromal-interaction molecule 1 (STIM1)-mediated store-operated Ca entry (SOCE) plays a key role in mediating cardiomyocyte hypertrophy, both in vitro and in vivo. Moreover, there is growing support for the contribution of SOCE to the Ca overload associated with ischemia/reperfusion injury. Therefore, STIM1 inhibition is proposed as a novel target for controlling both hypertrophy and ischemia/reperfusion-induced Ca overload. Our aim was to evaluate the effect of ML9, a STIM1 inhibitor, on cardiomyocyte viability. ML9 was found to induce cell death in cultured neonatal rat cardiomyocytes. Caspase-3 activation, apoptotic index and release of the necrosis marker lactate dehydrogenase to the extracellular medium were evaluated. ML9-induced cardiomyocyte death was not associated with increased intracellular ROS or decreased ATP levels. Moreover, treatment with ML9 significantly increased levels of the autophagy marker LC3-II, without altering Beclin1 or p62 protein levels. However, treatment with ML9 followed by bafilomycin-A1 did not produce further increases in LC3-II content. Furthermore, treatment with ML9 resulted in decreased LysoTracker® Green staining. Collectively, these data suggest that ML9-induced cardiomyocyte death is triggered by a ML9-dependent disruption of autophagic flux due to lysosomal dysfunction.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tiv.2018.01.005DOI Listing

Publication Analysis

Top Keywords

treatment ml9
12
stim1 inhibitor
8
ml9-induced cardiomyocyte
8
cardiomyocyte death
8
levels treatment
8
ml9
6
inhibitor ml9
4
ml9 disrupts
4
disrupts basal
4
basal autophagy
4

Similar Publications

We previously reported that the sustained component of contraction induced by depolarizing stimulation by high K concentration in rat caudal arterial smooth muscle involves a Ca-induced Ca sensitization mechanism whereby Ca entry through voltage-gated Ca channels activates proline-rich tyrosine kinase 2 (Pyk2), leading to activation of RhoA/Rho-associated kinase (ROCK). In the present study, we investigated a potential role for Pyk2-mediated RhoA/ROCK activation in contraction mediated by elevation of cytosolic free Ca concentration ([Ca]) induced by a Ca ionophore, ionomycin, rather than by depolarizing stimulation. Ionomycin (60 µM) induced slow and sustained contraction of rat caudal arterial smooth muscle due to influx of Ca.

View Article and Find Full Text PDF

The alkalinizing, lysosomotropic agent ML-9 induces a pH-dependent depletion of ER Ca stores in cellulo.

Biochim Biophys Acta Mol Cell Res

October 2022

KU Leuven, Laboratory of Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine, 3000 Leuven, Belgium. Electronic address:

ML-9 elicits a broad spectrum of effects in cells, including inhibition of myosin light chain kinase, inhibition of store-operated Ca entry and lysosomotropic actions that result in prostate cancer cell death. Moreover, the compound also affects endoplasmic reticulum (ER) Ca homeostasis, although the underlying mechanisms remain unclear. We found that ML-9 provokes a rapid mobilization of Ca from ER independently of IPRs or TMBIM6/Bax Inhibitor-1, two ER Ca-leak channels.

View Article and Find Full Text PDF

Background: Oxidative stress has a vital role in the early stages of vitiligo. Autoantigens released from apoptotic melanocytes (MC) under oxidative stress are involved in the presentation and recognition of antigens. However, the transport of autoantigens to the cell surface and their release to the extracellular environment are still unclear.

View Article and Find Full Text PDF

A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity.

Molecules

May 2020

Laboratório Nacional de Biociências (LNBio), Centro Nacional de Pesquisa em Energia e Materiais (CNPEM), Campinas, SP 13083-970, Brazil.

Article Synopsis
  • High genetic and phenotypic variability in leishmanial species makes it difficult to create broad-spectrum antileishmanial drugs, prompting the use of diverse species screening panels.
  • A high content assay was developed to screen 1280 small molecules against clinically relevant cutaneous and visceral leishmanial species using THP-1 macrophages, assessing both the drug's effectiveness and toxicity.
  • Out of 51 active compounds, only 14 demonstrated broad-spectrum efficacy, with a few showing over 70% activity, indicating a need for more comprehensive screening strategies for discovering effective antileishmanial agents.
View Article and Find Full Text PDF

We have shown progesterone exerts a direct action on vascular smooth muscle cells (VSMCs) to induce relaxation through activation of membrane progesterone receptor alpha (mPRα)-dependent signaling pathways, but information on downstream events is lacking. Progesterone-induced changes in calcium concentrations in human umbilical artery VSMCs through mPRα-dependent signaling pathways and the involvement of Rho/ROCK signaling were investigated. Acute in vitro treatment with progesterone and the selective mPRα agonist 10-ethenyl-19-norprogesterone (Org OD 02-0, 02-0) blocked the rapid prostaglandin F2α-induced calcium increase.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!